Using imaging to enhance immune responses against pancreatic cancer
Imaging Modulation of Immune Phenotype
This study is exploring new ways to help your immune system fight pancreatic cancer using tiny particles that deliver special treatments, and it aims to see how well these treatments work in real-time to potentially offer better options for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11006298 on NIH RePORTER |
What this research studies
This research focuses on developing innovative nanotherapeutics that can modulate the immune system to fight pancreatic cancer. By utilizing biodegradable nanoparticles that deliver immune-modulating peptides and toll-like receptor agonists, the study aims to enhance the body's immune response against tumors. The approach includes imaging techniques to monitor the effectiveness of these treatments in real-time, providing insights into how well the immune system is responding. Patients may benefit from new treatment options that could improve outcomes for pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer who are seeking innovative treatment options.
Not a fit: Patients with non-cancerous conditions or those who do not have pancreatic cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in using immune modulation strategies for cancer treatment, indicating potential for success with this novel approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Ferrara, Katherine W — Stanford University
- Study coordinator: Ferrara, Katherine W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.